Skip to main content
68°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Rocket Pharmaceuticals Inc
(NQ:
RCKT
)
18.59
+0.10 (+0.54%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Rocket Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
7
Next >
Why Is Rocket Pharmaceuticals (RCKT) Stock Up 35% Today?
September 13, 2023
With Rocket Pharmaceuticals reaching a Phase II agreement with the FDA, RCKT stock soared, though some concerns linger.
Via
InvestorPlace
Exposures
Product Safety
Why Eiger BioPharmaceuticals Shares Are Trading Lower By 52%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
September 13, 2023
Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares surged 68% to $0.2075. Avalo Therapeutics, on Sept 12, got notice from the Nasdaq as of Sept 11 the company’s securities had closing bid price of...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
September 13, 2023
Via
Benzinga
Rocket Pharmaceuticals Inc. (NASDAQ: RCKT) Near the Top of Equities by Percentage Gain on 9/13
September 13, 2023
Via
Investor Brand Network
Analyst Expectations for Rocket Pharmaceuticals's Future
September 13, 2023
Via
Benzinga
What 5 Analyst Ratings Have To Say About Rocket Pharmaceuticals
August 11, 2023
Via
Benzinga
Dow Gains 50 Points; US Crude Oil Inventories Rise
September 13, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 50 points on Wednesday. The Dow traded up 0.16% to 34,701.06 while the NASDAQ rose 0.44% to 13,834.85. The S&P 500,...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Shares of Rocket Pharmaceuticals Are Taking Off on Wednesday
September 13, 2023
The late-stage pharmaceutical company said it had reached an agreement with the Food and Drug Administration regarding a phase 2 trial for a Danon disease therapy.
Via
The Motley Fool
What's Going On With Gene Therapy-Focused Rocket Pharmaceuticals Stock Today?
September 13, 2023
On Tuesday, Rocket Pharmaceuticals Inc (NASDAQ: RCKT) announced that alignment has been reached with the FDA on the global Phase 2 pivotal trial of RP-A501
Via
Benzinga
Exposures
Product Safety
Moderna, REV Group, Rocket Pharmaceuticals And Other Big Stocks Moving Higher On Wednesday
September 13, 2023
U.S. stocks traded mixed, with the Dow Jones gaining around 10 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 13, 2023
Via
Benzinga
Expert Ratings for Rocket Pharmaceuticals
May 23, 2023
Via
Benzinga
Analyst Ratings for Rocket Pharmaceuticals
May 05, 2023
Via
Benzinga
Rocket Pharmaceuticals: Q1 Earnings Insights
May 04, 2023
Via
Benzinga
GoDaddy To Rally Around 44%? Here Are 10 Other Analyst Forecasts For Wednesday
September 13, 2023
Needham cut the price target for Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) from $60 to $53. Needham analyst Gil Blum maintained a Buy rating. Rocket Pharmaceuticals shares rose 24.3% to $19.00 in...
Via
Benzinga
Why Mainz Biomed Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
September 13, 2023
Gainers Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares rose 38.7% to $0.1713 in pre-market trading. Shares of Avalo Therapeutics jumped over 45% on Tuesday after the company agreed to divest AVTX-800...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
September 13, 2023
It's time for another dive into the biggest pre-market stock movers as we check out all the shares worth watching on Wednesday!
Via
InvestorPlace
Rocket Pharmaceuticals Announces Pricing of Public Offering of Common Stock
September 13, 2023
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 12, 2023
Via
Benzinga
Rocket Pharmaceuticals Announces Proposed Public Offering of Common Stock
September 12, 2023
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Rocket Pharmaceuticals Reaches FDA Alignment on Pivotal Phase 2 Trial Design for RP-A501 in Danon Disease
September 12, 2023
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
September 06, 2023
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Rocket Pharmaceuticals Reports Second Quarter 2023 Financial Results and Highlights Recent Progress
August 10, 2023
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
3 Small-Cap Stocks You Can’t Ignore Now
June 12, 2023
Finding promising small-cap stocks can be like a winning lottery ticket, providing years of steady and increasing gains to investors.
Via
InvestorPlace
Rocket Pharmaceuticals Inc. (NASDAQ: RCKT) Sets New 52-Week High in Friday Session
June 09, 2023
Via
Investor Brand Network
Rocket Pharmaceuticals Receives FDA Fast Track and Orphan Drug Designations for RP-A601 Gene Therapy for PKP2 Arrhythmogenic Cardiomyopathy (ACM)
June 08, 2023
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Rocket Pharmaceuticals Receives European Medicines Agency (EMA) Priority Medicines (PRIME) Designation for RP-A501 Gene Therapy for Danon Disease
May 31, 2023
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RP-L301 Gene Therapy for Pyruvate Kinase Deficiency (PKD)
May 23, 2023
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Rocket Pharmaceuticals Presents Positive Data from LV Hematology and AAV Cardiovascular Gene Therapy Programs at the 26th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
May 19, 2023
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
Rocket Pharmaceuticals Announces FDA Clearance of IND for Clinical Trial of RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy (ACM)
May 09, 2023
From
Rocket Pharmaceuticals, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.